Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Oct 29, 2003

Mylan Reports Record Quarterly Earnings of $0.33 Per Diluted Share; Record Revenues and Net Earnings also Reported, as well as Another Record Quarter for the Generic Segment

Oct 28, 2003

Mylan Agrees to Sell Sertaconazole Licensing Rights to Ortho Neutrogena for $14 Million

Oct 15, 2003

Mylan Announces Second Quarter Fiscal 2004 Earnings Release and Conference Call Dates

Oct 10, 2003

Mylan Updates Litigation Status

Oct 06, 2003

Mylan Dismissed from Massachusetts Multi-District AWP Litigation, Updates Litigation Status

Sep 16, 2003

Mylan Receives FDA Approval for Nefazodone Hydrochloride Tablets

Sep 16, 2003

Mylan Announces Three-for-Two Stock Split

Sep 15, 2003

Mylan Declares Regular Quarterly Cash Dividend

Sep 11, 2003

Mylan Receives FDA Approval for Midodrine Hydrochloride Tablets

Aug 21, 2003

Mylan Laboratories and Watson Pharmaceuticals Announce FDA Acceptance of Resubmission of New Drug Application for EMSAM Antidepressant Patch

Pagination

First page
Previous page
…
Page 119
Page 120
Page 121
Page 122
Current page 123
Page 124
Page 125
Page 126
Page 127
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.